CSF receptor
9 drugs2
approved indications
9
Approved Drugs
9
Companies
4
Indications
0
Therapeutic Areas
Top Drugs
Unlock Full Target Intelligence PRO
✓ Competitive landscape by company (9 companies)
✓ All 9 approved drugs
✓ Therapeutic area breakdown
✓ Full indication list (4 indications)
✓ Patent cliff analysis
✓ Clinical trials pipeline
Upgrade to Pro
Starting at $99/mo
Drugs by Company
EVIVE BIOTECHNOLOGY 1 drug
KASHIV BIOSCIENCES LLC 1 drug
Amgen 1 drug
By Therapeutic Area
Other 9 drugs
By Therapeutic Area
Other 9 drugs
RYZNEUTA, FYLNETRA, NEULASTA, UDENYCA +5 more
Indications Treated
Febrile NeutropeniaNon-Myeloid MalignanciesAcute Radiation SyndromeInfection
All Drugs Targeting CSF receptor
| Drug | Company | Approved | Indications | Therapeutic Area |
|---|---|---|---|---|
| RYZNEUTA | EVIVE BIOTECHNOLOGY | 2023 | 2 | |
| FYLNETRA | KASHIV BIOSCIENCES LLC | 2022 | 2 | |
| NEULASTA | Amgen | 2002 | 2 | |
| UDENYCA | COHERUS BIOSCIENCES INC | 2018 | 2 | |
| ZIEXTENZO | Novartis | 2019 | 2 | |
| ARMLUPEG | Lupin | 2025 | 2 | |
| NYVEPRIA | Pfizer | 2020 | 2 | |
| FULPHILA | Viatris | 2018 | 2 | |
| STIMUFEND | Fresenius Kabi | 2022 | 2 |